Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Junwei Pharmaceutical is a healthcare company based in Nanning, China, specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM), chemical generic drugs, and in vitro diagnostic (IVD) products. The company's commercial portfolio includes a variety of oral solid dosage forms, such as tablets, capsules, and granules, targeting respiratory and cardiovascular health. Key products include Compound Isatis Root Granules and Vitamin C Yinqiao Tablets, which are widely distributed in the Chinese domestic market. Operating through its main pharmaceutical entity and its biotechnology arm, Guangxi Nanning Junwei Biotechnology, the company maintains GMP-certified production facilities in the Nanning High-tech Industrial Development Zone. Junwei Pharmaceutical is recognized as a regional high-tech enterprise and a significant contributor to the pharmaceutical industry in the Guangxi Zhuang Autonomous Region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Nanning Junwei.